ADCs: Requirements in terms of GMP and occupational safety - PART 1 The challenges presented by a new generation of highly active pharmaceutical products for cancer treatment

摘要

ADCs (antibody drug conjugates) are a new generation of highly active pharmaceutical products used, among other things, in the targeted treatment of cancer. For health and safety reasons. most of these ADCs require containment in the double or triple-digit ng/m(3) range.